These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 24915493
1. Transplantation of mesenchymal stem cells recruits trophic macrophages to induce pancreatic beta cell regeneration in diabetic mice. Cao X, Han ZB, Zhao H, Liu Q. Int J Biochem Cell Biol; 2014 Aug; 53():372-9. PubMed ID: 24915493 [Abstract] [Full Text] [Related]
2. Impact of different pancreatic microenvironments on improvement in hyperglycemia and insulin deficiency in diabetic rats after transplantation of allogeneic mesenchymal stromal cells. Katuchova J, Tothova T, Farkasova Iannaccone S, Toporcer T, Harvanova D, Hildebrand T, Kilik R, Bacenkova D, Frohlichova L, Rosocha J, Bobrov N, Radonak J. J Surg Res; 2012 Nov; 178(1):188-95. PubMed ID: 22480834 [Abstract] [Full Text] [Related]
3. Transplanted human bone marrow progenitor subtypes stimulate endogenous islet regeneration and revascularization. Bell GI, Broughton HC, Levac KD, Allan DA, Xenocostas A, Hess DA. Stem Cells Dev; 2012 Jan; 21(1):97-109. PubMed ID: 21417581 [Abstract] [Full Text] [Related]
4. Transplantation of insulin-producing cells differentiated from human periosteum-derived progenitor cells ameliorate hyperglycemia in diabetic mice. Dao LT, Park EY, Lim SM, Choi YS, Jung HS, Jun HS. Transplantation; 2014 Nov 27; 98(10):1040-7. PubMed ID: 25208321 [Abstract] [Full Text] [Related]
5. Co-transplantation of mesenchymal stromal cells and cord blood cells in treatment of diabetes. Xiao N, Zhao X, Luo P, Guo J, Zhao Q, Lu G, Cheng L. Cytotherapy; 2013 Nov 27; 15(11):1374-84. PubMed ID: 24094489 [Abstract] [Full Text] [Related]
6. Bone marrow (BM) transplantation promotes beta-cell regeneration after acute injury through BM cell mobilization. Hasegawa Y, Ogihara T, Yamada T, Ishigaki Y, Imai J, Uno K, Gao J, Kaneko K, Ishihara H, Sasano H, Nakauchi H, Oka Y, Katagiri H. Endocrinology; 2007 May 27; 148(5):2006-15. PubMed ID: 17255204 [Abstract] [Full Text] [Related]
7. Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice. Yaochite JN, Caliari-Oliveira C, de Souza LE, Neto LS, Palma PV, Covas DT, Malmegrim KC, Voltarelli JC, Donadi EA. Stem Cell Res Ther; 2015 Mar 14; 6(1):31. PubMed ID: 25884215 [Abstract] [Full Text] [Related]
8. Mesenchymal stroma cells improve hyperglycemia and insulin deficiency in the diabetic porcine pancreatic microenvironment. Chang C, Niu D, Zhou H, Zhang Y, Li F, Gong F. Cytotherapy; 2008 Mar 14; 10(8):796-805. PubMed ID: 18979304 [Abstract] [Full Text] [Related]
9. Bone marrow mesenchymal stem cells promote the repair of islets from diabetic mice through paracrine actions. Gao X, Song L, Shen K, Wang H, Qian M, Niu W, Qin X. Mol Cell Endocrinol; 2014 May 05; 388(1-2):41-50. PubMed ID: 24667703 [Abstract] [Full Text] [Related]
10. Direct comparison of the abilities of bone marrow mesenchymal versus hematopoietic stem cells to reverse hyperglycemia in diabetic NOD.SCID mice. Arany EJ, Waseem M, Strutt BJ, Chamson-Reig A, Bernardo A, Eng E, Hill DJ. Islets; 2018 May 05; 10(4):137-150. PubMed ID: 30110202 [Abstract] [Full Text] [Related]
11. Transplantation of mesenchymal stem cells improves type 1 diabetes mellitus. Li L, Li F, Gao F, Yang Y, Liu Y, Guo P, Li Y. Cell Tissue Res; 2016 May 05; 364(2):345-55. PubMed ID: 26650464 [Abstract] [Full Text] [Related]
12. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice. Ezquer FE, Ezquer ME, Parrau DB, Carpio D, Yañez AJ, Conget PA. Biol Blood Marrow Transplant; 2008 Jun 05; 14(6):631-40. PubMed ID: 18489988 [Abstract] [Full Text] [Related]
13. Bone marrow transplantation stimulates pancreatic β-cell replication after tissue damage. Rosengren AH, Taneera J, Rymo S, Renström E. Islets; 2009 Jun 05; 1(1):10-8. PubMed ID: 21084844 [Abstract] [Full Text] [Related]
14. Intrapancreatic injection of human bone marrow-derived mesenchymal stem/stromal cells alleviates hyperglycemia and modulates the macrophage state in streptozotocin-induced type 1 diabetic mice. Murai N, Ohtaki H, Watanabe J, Xu Z, Sasaki S, Yagura K, Shioda S, Nagasaka S, Honda K, Izumizaki M. PLoS One; 2017 Jun 05; 12(10):e0186637. PubMed ID: 29073149 [Abstract] [Full Text] [Related]
19. Transplantation of betatrophin-expressing adipose-derived mesenchymal stem cells induces β-cell proliferation in diabetic mice. Sun LL, Liu TJ, Li L, Tang W, Zou JJ, Chen XF, Zheng JY, Jiang BG, Shi YQ. Int J Mol Med; 2017 Apr 05; 39(4):936-948. PubMed ID: 28290605 [Abstract] [Full Text] [Related]
20. Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes. Urbán VS, Kiss J, Kovács J, Gócza E, Vas V, Monostori E, Uher F. Stem Cells; 2008 Jan 05; 26(1):244-53. PubMed ID: 17932424 [Abstract] [Full Text] [Related] Page: [Next] [New Search]